Immunome, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.80 | -$0.55 | -$0.68 |
| Q2 2024 | 1 | -$0.45 | -$0.31 | -$0.38 |
| Q3 2024 | 1 | -$0.65 | -$0.45 | -$0.55 |
| Q4 2024 | 3 | -$0.74 | -$0.59 | -$0.66 |
| Q1 2025 | 1 | -$0.82 | -$0.57 | -$0.70 |
| Q2 2025 | 1 | -$0.84 | -$0.58 | -$0.71 |
| Q3 2025 | 1 | -$0.86 | -$0.59 | -$0.73 |
| Q4 2025 | 1 | -$0.91 | -$0.63 | -$0.77 |
| Q1 2026 | 1 | -$0.82 | -$0.57 | -$0.70 |
| Q2 2026 | 1 | -$0.83 | -$0.57 | -$0.70 |
| Q3 2026 | 1 | -$0.84 | -$0.58 | -$0.71 |
| Q4 2026 | 1 | -$0.77 | -$0.53 | -$0.65 |
| Q1 2027 | 1 | -$0.73 | -$0.50 | -$0.62 |
| Q2 2027 | 1 | -$0.68 | -$0.47 | -$0.58 |
| Q3 2027 | 1 | -$0.59 | -$0.41 | -$0.50 |
| Q4 2027 | 1 | -$0.50 | -$0.34 | -$0.42 |
Immunome, Inc. Earnings Date And Information
Immunome, Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $-0.49 earnings per share for the quarter, missing analysts' consensus estimates of $-0.38 by $0.11. The company had revenue of 2.91 M for the quarter and had revenue of 14.02 M for the year. Immunome, Inc. has generated $-5 earnings per share over the last year ($-5.38 diluted earnings per share) and currently has a price-to-earnings ratio of -1.94. Immunome, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
Immunome, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.78 | $2.29 M | $2.91 M | ||
| 08/12/2024 | Q2 2024 | -$0.38 | -$0.60 | -0.22 | $1.87 M | $2.36 M |
| 05/14/2024 | Q1 2024 | -$0.80 | -$12.56 | -11.76 | $1.03 M | |
| 03/28/2024 | Q4 2023 | -$0.28 | -$4.22 | -3.94 | $3.83 M | |
| 11/09/2023 | Q3 2023 | -$0.36 | $3.57 M | |||
| 08/09/2023 | Q2 2023 | -$0.16 | -$0.46 | -0.3 | $4.26 M | |
| 05/05/2023 | Q1 2023 | $0.59 | -$0.33 | -0.92 | $2.36 M | |
| 03/16/2023 | Q4 2022 | $0.67 | -$0.69 | -1.36 | $0 | |
| 11/14/2022 | Q3 2022 | -$0.76 | -$0.70 | 0.06 | $0 | |
| 08/05/2022 | Q2 2022 | -$0.75 | -$0.74 | 0.01 | $0 | |
| 05/12/2022 | Q1 2022 | -$0.69 | -$0.96 | -0.27 | $0 | |
| 03/28/2022 | Q4 2021 | -$0.81 | -$0.66 | 0.15 | $0 | |
| 11/15/2021 | Q3 2021 | -$0.50 | -$0.65 | -0.15 | $0 | |
| 08/16/2021 | Q2 2021 | -$0.39 | -$0.46 | -0.07 | $0 | |
| 05/12/2021 | Q1 2021 | -$0.41 | -$0.37 | 0.04 | $0 | |
| 03/25/2021 | Q4 2020 | -$0.29 | -$0.40 | -0.11 | $0 | |
| 11/16/2020 | Q3 2020 | -$0.38 | -$0.83 | -0.45 | $390,500 | $0 |
| 06/29/2020 | Q2 2020 | -$0.29 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.47 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.51 | $0 |
Immunome, Inc. Earnings: Frequently Asked Questions
-
When is Immunome, Inc.'s earnings date?
Immunome, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates.
-
How can I listen to Immunome, Inc.'s earnings conference call?
The conference call for Immunome, Inc.'s latest earnings report can be listened to online.
-
How can I read Immunome, Inc.'s conference call transcript?
The conference call transcript for Immunome, Inc.'s latest earnings report can be read online.
-
How much revenue does Immunome, Inc. generate each year?
Immunome, Inc. (:IMNM) has a recorded annual revenue of $14.02 M.
-
How much profit does Immunome, Inc. generate each year?
Immunome, Inc. (:IMNM) has a recorded net income of $14.02 M. Immunome, Inc. has generated $-5.38 earnings per share over the last four quarters.
-
What is Immunome, Inc.'s price-to-earnings ratio?
Immunome, Inc. (:IMNM) has a price-to-earnings ratio of -1.94 and price/earnings-to-growth ratio is 0.82.
